Literature DB >> 30151689

Use of time-varying coefficients in a Cox regression model when the proportional hazard assumption is violated.

Maofeng Wang1, Weimin Li2, Nadir Yehya3, Garrett Keim3, Neal J Thomas4.   

Abstract

Mesh：

Year:  2018        PMID： 30151689     DOI： 10.1007/s00134-018-5351-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

1.  Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.

Authors:  Carolyn S Calfee; Kevin Delucchi; Polly E Parsons; B Taylor Thompson; Lorraine B Ware; Michael A Matthay
Journal:  Lancet Respir Med       Date:  2014-05-19       Impact factor: 30.700

2.  Survival analysis in the presence of competing risks.

Authors:  Zhongheng Zhang
Journal:  Ann Transl Med       Date:  2017-02

3.  Time-varying covariates and coefficients in Cox regression models.

Authors:  Zhongheng Zhang; Jaakko Reinikainen; Kazeem Adedayo Adeleke; Marcel E Pieterse; Catharina G M Groothuis-Oudshoorn
Journal:  Ann Transl Med       Date:  2018-04

4.  Subtypes of pediatric acute respiratory distress syndrome have different predictors of mortality.

Authors:  Nadir Yehya; Garrett Keim; Neal J Thomas
Journal:  Intensive Care Med       Date:  2018-07-03       Impact factor: 17.440

5.  Competing risk regression models for epidemiologic data.

Authors:  Bryan Lau; Stephen R Cole; Stephen J Gange
Journal:  Am J Epidemiol       Date:  2009-06-03       Impact factor: 4.897

6.  Survival methods, including those using competing risk analysis, are not appropriate for intensive care unit outcome studies.

Authors:  David Schoenfeld
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097
  6 in total
  1 in total

1.  'Lumping or splitting' in paediatric acute respiratory distress syndrome (PARDS).

Authors:  Daniele De Luca; David A Harrison; Mark J Peters
Journal:  Intensive Care Med       Date:  2018-08-24       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.